美股异动 | FDA出现重大人事变动 部分生物制药公司股价飙升

智通财经
Jul 30
【美股异动 | FDA出现重大人事变动 部分生物制药公司股价飙升】智通财经APP获悉,周三,部分生物制药公司股价飙升,截至发稿,Replimune(REPL.US)飙升逾85%,Sarepta Therapeutics (SRPT.US)上涨超16%,Capricor Therapeutics(CAPR.US)大涨超18%。消息面上,美国FDA生物制品评估与研究中心主任普拉萨德在上任不到三个月后离职,正值FDA对多款基因疗法和疫苗采取严格监管措施,引发市场关注。分析人士指出,他的离任可能有助于缓解监管压力,被视为基因疗法和疫苗企业的利好消息。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10